Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PDD for intraoperative detection of peritoneal dissemination in ovarian cancer
jRCTs051240230Active, not recruiting
- Sponsor
- Grant-in-Aid for Early-Career Scientists
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by Grant-in-Aid for Early-Career Scientists. Primary endpoint: Sensitivity and specificity of ALA-PDD for peritoneal dissemination detection. Started Mar 2025; status: active, not recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on jRCTs051240230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240230.